Studies indicate that GHK-Cu may stimulate the production of collagen types I, III, and V, as well as elastin, decorin, and glycosaminoglycans in fibroblast cell cultures
2023 at: Kaur, P., Chaudhry, C., Panigrahi, I., Srivastava, P., & Kaur, A
Phase 1b/2a Subcutaneous Formulation (Obesity) Published: The Lancet, June 2025 Participants: 125 adults with overweight or obesity (BMI 27.039.9), aged 1855 Duration: Up to 36 weeks Dosing: Once-weekly subcutaneous amycretin, up to 60 mg Results: - Up to 22% absolute weight loss at 36 weeks (highest dose group) - Placebo-adjusted difference: approximately 24% - No weight-loss plateau observed at study end Safety: 81% of the 89 participants who reported a TEAE had gastrointestinal events
Therefore, 10 units equals 0.10 mL and 25 units equals 0.25 mL
And if youre considering NAD IV therapy in Sedona, knowing how it compares to glutathione IVs is a great way to start